Vaccines can be an incredibly effective health intervention, but current vaccination efforts in the developing world are hampered by uncertainty of actual coverage. To help address this, Diagnostics for All has been awarded a three-year, $2.6M grant from the Bill & Melinda Gates Foundation to develop a rapid diagnostic test for immune markers of successful vaccination against tetanus and measles in children. Additionally, this diagnostic will be able to identify recent exposure to measles, usually a sign that current vaccination efforts need to be improved. With the assistance of a diverse team of partners, we will develop a tool that will enable more accurate assessments of immunization programs and, hopefully, better coverage for these diseases of high global priority.
About Diagnostics For All
Incorporated in 2007, Diagnostics For All is a 501(c)(3) non-profit enterprise creating low-cost, easy-to-use point-of-care diagnostic devices specifically designed for the developing world. These devices are elegantly simple and inexpensive. They require minimal training to use, minimal sample preparation, and no electricity or additional equipment. For more information, visit www.dfa.org or email email@example.com.